FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32)

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3368-3379

  Bhatnagar, Nupur ^a   Ahmad, Fareed ^a   Hong, Henoch S ^b   Eberhard, Johanna ^a   Lu, I Na ^a   Ballmaier, Matthias ^a   Schmidt, Reinhold E ^a   Jacobs, Roland ^a   Meyer Olson, Dirk ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c M and i Fachklinik Bad Pyrmont   (Germany)

Author keywords

ADCC; Fc receptors; Monocytes; NK cells

Indexed keywords

FC RECEPTOR; FCGR2B PROTEIN, HUMAN; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; BIOSYNTHESIS; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MONOCYTE; NATURAL KILLER CELL;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; GPI-LINKED PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MONOCYTES; RECEPTORS, IGG;

EID: 84916888074     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444515     Document Type: Article

References (47)

1. Caligiuri, M. A., Human natural killer cells. Blood 2008. 112: 461-469.
2. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011. 331: 44-49.
3. Nimmerjahn, F. and Ravetch, J. V., Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 2008. 8: 34-47.
4. Nimmerjahn, F. and Ravetch, J. V., FcγRs in health and disease. Curr. Top Microbiol. Immunol. 2011. 350: 105-125.
5. Smith, K. G. and Clatworthy, M. R., FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 2010. 10: 328-343.
6. Morel, P. A., Ernst, L. K. and Metes, D., Functional CD32 molecules on human NK cells. Leuk. Lymphoma 1999. 35: 47-56.
7. Hatjiharissi, E., Xu, L., Santos, D. D., Hunter, Z. R., Ciccarelli, B. T., Verselis, S., Modica, M. et al., Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V/V and V/F polymorphism. Blood 2007. 110: 2561-2564.
8. Dall'Ozzo, S., Tartas, S., Paintaud, G., Cartron, G., Colombat, P., Bardos, P., Watier, H. et al., Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res. 2004. 64: 4664-4669.
9. Clatworthy, M. R., Willcocks, L., Urban, B., Langhorne, J., Williams, T. N., Peshu, N., Watkins, N. A. et al., Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc. Natl. Acad. Sci. USA 2007. 104: 7169-7174.
10. Gjertsson, I., Kleinau, S. and Tarkowski, A., The impact of Fcgamma receptors on Staphylococcus aureus infection. Microb. Pathog. 2002. 33: 145-152.
11. Tarzi, R. M., Davies, K. A., Claassens, J. W., Verbeek, J. S., Walport, M. J. and Cook, H. T., Both Fcgamma receptor I and Fcgamma receptor III mediate disease in accelerated nephrotoxic nephritis. Am. J. Pathol. 2003. 162: 1677-1683.
12. Zingoni, A., Sornasse, T., Cocks, B. G., Tanaka, Y., Santoni, A. and Lanier, L. L., NK cell regulation of T cell-mediated responses. Mol. Immunol. 2005. 42: 451-454.
13. Blanca, I. R., Bere, E. W., Young, H. A. and Ortaldo, J. R., Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells. J. Immunol. 2001. 167: 6132-6139.
14. Cooper, M. A., Fehniger, T. A., Fuchs, A., Colonna, M. and Caligiuri, M. A., NK cell and DC interactions. Trends Immunol. 2004. 25: 47-52.
15. Degli-Esposti, M. A. and Smyth, M. J., Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 2005. 5: 112-124.
16. Newman, K. C., Korbel, D. S., Hafalla, J. C. and Riley, E. M., Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria. PLoS Pathog. 2006. 2: e118.
17. Bhatnagar, N., Hong, H. S., Krishnaswamy, J. K., Haghikia, A., Behrens, G. M., Schmidt, R. E. and Jacobs, R., Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood 2010. 116: 1308-1316.
18. Soderquest, K., Powell, N., Luci, C., van Rooijen, N., Hidalgo, A., Geissmann, F., Walzer, T. et al., Monocytes control natural killer cell differentiation to effector phenotypes. Blood 2011. 117: 4511-4518.
19. Waggoner, S. N., Cornberg, M., Selin, L. K. and Welsh, R. M., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012. 481: 394-398.
20. Mogensen, T. H., Melchjorsen, J., Larsen, C. S. and Paludan, S. R., Innate immune recognition and activation during HIV infection. Retrovirology 2010. 7: 54.
21. Deeks, S. G., HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 2011. 62: 141-155.
22. + NK cell-like phenotype and correlates with HIV viral load. PLoS One 2012. 7: e44820.
23. Hong, H. S., Eberhard, J. M., Keudel, P., Bollmann, B. A., Ahmad, F., Ballmaier, M., Bhatnagar, N. et al., Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection. AIDS 2010. 24: 1823-1834.
24. Hong, H. S., Eberhard, J. M., Keudel, P., Bollmann, B. A., Ballmaier, M., Bhatnagar, N., Zielinska-Skowronek, M. et al., HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J. Virol. 2010. 84: 1183-1188.
25. Ackerman, M. E., Dugast, A. S. and Alter, G., Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. Annu. Rev. Med. 2012. 63: 113-130.
26. Thobakgale, C. F., Fadda, L., Lane, K., Toth, I., Pereyra, F., Bazner, S., Ndung'u, T. et al., Frequent and Strong Antibody-Mediated Natural Killer Cell Activation in Response to HIV-1 Env in Individuals with Chronic HIV-1 Infection. J. Virol. 2012. 86: 6986-6993.
27. Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. et al., Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007. 449: 101-104.
28. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N. et al., Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009. 361: 2209-2220.
29. Dugast, A. S., Tonelli, A., Berger, C. T., Ackerman, M. E., Sciaranghella, G., Liu, Q., Sips, M. et al., Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. Virology 2011. 415: 160-167.
30. Perussia, B. and Loza, M. J., Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cells. Methods Mol. Biol. 2000. 121: 179-192.
31. Mavilio, D., Benjamin, J., Daucher, M., Lombardo, G., Kottilil, S., Planta, M. A., Marcenaro, E. et al., Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 2003. 100: 15011-15016.
32. Fauci, A. S., Mavilio, D. and Kottilil, S., NK cells in HIV infection: paradigm for protection or targets for ambush. Nat. Rev. Immunol. 2005. 5: 835-843.
33. Lichtfuss, G. F., Meehan, A. C., Cheng, W. J., Cameron, P. U., Lewin, S. R., Crowe, S. M. and Jaworowski, A., HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity. J. Leukoc. Biol. 2011. 89: 149-158.
34. Dalbeth, N., Gundle, R., Davies, R. J., Lee, Y. C., McMichael, A. J. and Callan, M. F., CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 2004. 173: 6418-6426.
35. Welte, S., Kuttruff, S., Waldhauer, I. and Steinle, A., Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 2006. 7: 1334-1342.
36. Kloss, M., Decker, P., Baltz, K. M., Baessler, T., Jung, G., Rammensee, H. G., Steinle, A. et al., Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J. Immunol. 2008. 181: 6711-6719.
37. Beum, P. V., Lindorfer, M. A. and Taylor, R. P., Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving. J. Immunol. 2008. 181: 2916-2924.
38. Ernst, L. K., Metes, D., Herberman, R. B. and Morel, P. A., Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells. J. Mol. Med. 2002. 80: 248-257.
39. van der Heijden, J., Breunis, W. B., Geissler, J., de Boer, M., van den Berg, T. K. and Kuijpers, T. W., Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J. Immunol. 2012. 188: 1318-1324.
40. Dutertre, C. A., Bonnin-Gélizé, E., Pulford, K., Bourel, D., Fridman, W. H. and Teillaud, J. L., A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent function. J. Leukoc. Biol. 2008. 84: 1511-1520.
41. Starbeck-Miller, G. R., Badovinac, V. P., Barber, D. L. and Harty, J. T., Cutting Edge: Expression of FcγRIIB Tempers Memory CD8 T Cell Function In Vivo. J. Immunol. 2014. 192: 35-39.
42. Clynes, R. A., Towers, T. L., Presta, L. G. and Ravetch, J. V., Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat. Med. 2000. 6: 443-446.
43. Naziruddin, B., Duffy, B. F., Tucker, J. and Mohanakumar, T., Evidence for cross-regulation of Fc gamma RIIIB (CD16) receptor-mediated signaling by Fc gamma RII (CD32) expressed on polymorphonuclear neutrophils. J. Immunol. 1992. 149: 3702-3709.
44. Hong, H. S., Bhatnagar, N., Ballmaier, M., Schubert, U., Henklein, P., Volgmann, T., Heiken, H. et al., Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay. Immunol. Lett. 2009. 125: 100-104.
45. Coleman, C. M. and Wu, L., HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009. 6: 51.
46. Ansari, A. W., Bhatnagar, N., Dittrich-Breiholz, O., Kracht, M., Schmidt, R. E. and Heiken, H., Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals. Int. Immunol. 2006. 18: 1443-1451.
47. Forthal, D. N., Landucci, G., Bream, J., Jacobson, L. P., Phan, T. B. and Montoya, B., FcgammaRIIa genotype predicts progression of HIV infection. J. Immunol. 2007. 179: 7916-7923.